Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Barinthus Biotherapeutics plc - American Depositary Shares (NQ: BRNS ) 1.250 -0.050 (-3.85%) Streaming Delayed Price Updated: 1:34 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Barinthus Biotherapeutics plc - American Depositary Shares BRNS Stock Earnings: Barinthus Biotherapeutics Misses EPS for Q2 2024 August 08, 2024 BRNS stock results show that Barinthus Biotherapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket June 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q1 2024 May 13, 2024 BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga Barinthus Biotherapeutics: Q4 Earnings Insights March 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives April 19, 2024 Explore the latest findings from Barinthus Biotherapeutics on VTP-200's performance in the APOLLO trial for low-grade cervical lesions linked to persistent hrHPV infection. Positive trends were noted,... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 03, 2024 Via Benzinga BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q4 2023 March 20, 2024 BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session February 19, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.